| CTRI Number |
CTRI/2025/04/085775 [Registered on: 28/04/2025] Trial Registered Prospectively |
| Last Modified On: |
24/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Assessing the Effectiveness of Internal Administration of Gandharvahasthadi Yamakam in Alleviating Menstrual Pain in Females of Age Group 18-35 Years |
|
Scientific Title of Study
|
Effect of Gandharvahasthadi yamakam in primary dysmenorrhea |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sneha K |
| Designation |
PG Scholar |
| Affiliation |
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy |
| Address |
Room no 09
Department of Prasutitantra evum Streeroga
PNNM Ayurveda Medical College and Hospital, Cheruthuruthy Thrissur
Thrissur KERALA 679531 India |
| Phone |
9048385357 |
| Fax |
|
| Email |
kasyapsnehakasyap@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr salini P |
| Designation |
Professor and HOD |
| Affiliation |
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy |
| Address |
Room no 09
Department of Prasutitantra evum Streeroga
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy Thrissur
Thrissur KERALA 679531 India |
| Phone |
9048385357 |
| Fax |
|
| Email |
salipkavungal@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Sithara Satheesan |
| Designation |
Associate professor |
| Affiliation |
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy |
| Address |
Room no 09
Department of Prasutitantra evum Streeroga
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy Thrissur
Thrissur KERALA 679531 India |
| Phone |
9048385357 |
| Fax |
|
| Email |
sitharasatheesan@gmail.com |
|
|
Source of Monetary or Material Support
|
| PNNM Ayurveda Medical College and Hospital,Cheruthuruthy Thrissur,Kerala,India
679 531 |
|
|
Primary Sponsor
|
| Name |
Dr Sneha K |
| Address |
PNNM Ayurveda Medical College and Hospital,Cheruthuruthy Thrissur,Kerala,India
679531 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sneha K |
PNNM Ayurveda Medical College and Hospital |
Room no 09
Department of Prasutitantra evum Streeroga Thrissur KERALA |
9048385357
kasyapsnehakasyap@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Comittee PNNM Ayurveda Medical College and Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Gandharvahasthadiyamakam, Reference: Chikitsamanjari, Route: Oral, Dosage Form: Ghrita, Dose: 12(ml), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 10 Days, anupAna/sahapAna: Yes(details: -luke warm water), Additional Information: shoola chikitsa
udhavartha chikitsa adhikara |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
35.00 Year(s) |
| Gender |
Female |
| Details |
1.Subjects with regular menstrual cycle of 28-30
days interval
2.Age group between 18-35 years
3.Subjects satisfying diagnostic criteria asper SOGC
|
|
| ExclusionCriteria |
| Details |
1.Subjects who are planning for pregnancy
2.Known case of systemic illness
3.Dysfunctional uterine bleeding
4.Structural abnormality of reproductive system
5.Lactating women
6.Pelvic pathology reported in USG
•Subjects with mandagni assessed using agnibala assessment tool
•Subjects having mridu koshta assessed using koshta assessment tool
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reducing pain in primary dysmenorrhea |
First assessment before treatment
Second assessment on the 4th day of menstrual cycle after intervention
Third assessment is follow-up assessment after 4 weeks
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reducing associated symptoms in primary dysmenorrhea |
First assessment before treatment
Second assessment on 4th day of menstrual cycle after intervention
Third assessment is follow-up assessment |
|
|
Target Sample Size
|
Total Sample Size="36" Sample Size from India="36"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
10/05/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This single-arm trial aims to investigate the effectiveness of Gandharvahasthadi Yamakam in alleviating the symptoms of primary dysmenorrhea in subjects aged 18-35 years .The study involves 36 participants who will be given 12ml of Gandharvahasthadi Yamakam from the 22nd day of one menstrual cycle to the 3rd day of the next cycle. Assessments will be taken before teatment, post-intervention (on the 4th day of the cycle), and at follow-up assessment (after 4 weeks) to evaluate the potential benefits of this Ayurvedic medicine in reducing pain and associated symptoms primary dysmenorrhea. |